Active Ingredient: Ranitidine hydrochloride — a histamine‑2 receptor antagonist that reduces gastric acid secretion by blocking H₂ receptors on stomach parietal cells .
Typically supplied as 50 mg in 2 mL vials (25 mg/mL) for IV or IM use .
Find products similar to Renorep, Ranitidine Hydrochloride Injection IP, 25 Mg/ml
